Is It Time to Buy This Growth Stock?
Specialty and generic drugmaker Actavis has been going through a rapid growth spurt, spurred by its numerous acquisitions. After completing a mega merger with Botox-maker Allergan, can the uptrend continue?
The 3 Most Memorable Moments in Healthcare This Year
Three Motley Fool analysts tell investors what they believe are the year's most memorable events in the healthcare sector.
Consumer Health Spending a Welcome Wrinkle for Allergan-Actavis Deal
With consumer spending on "descrtionary items" like elective healthcare procedures, treatments and products on the rise, the combined Actavis and Allergan with its portfolio of cosmetic drugs like Botox will benefit.